Gain Therapeutics, Inc. Rings the Closing Bell
About This Event
Gain Therapeutics, Inc. (Nasdaq: GANX), a leading biotechnology company focused on the discovery and development of allosteric small molecule therapies that are disease agnostic, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Matthias Alder, President & Chief Executive Officer, rings the Closing Bell.